OBJECTIVES:  This study retrospectively examines medical records of patients newly diagnosed with type 2 diabetes mellitus. We assess potential contributing factors and statin use, while evaluating patients’ current diabetes control compared to national standards. METHODS:  A United States retrospective medical chart review of 1000 randomly selected adult patients with new onset diabetes, identified from 5 Accountable Care Organizations (ACOs), was conducted. Patients had a current diagnosis of diabetes (ICD-9 codes 250.00-250.93) in the study timeframe of January 1st 2013-December 31st 2014, and had at least one recorded follow-up visit after diagnosis. Patient demographics, comorbidities, blood pressure control, LDL screening and A1c level data were collected from the medical record and analyzed using t-tests or chi-square tests where appropriate. Analyses were stratified by statin use and A1c levels. RESULTS:  The sample was 51% male and 49% Caucasian with a mean age of 66 ± 12.7 years. A total of 501 (50.1%) diabetes patients were on a statin by the end of the study period. Patients on a statin were significantly more likely to have blood pressure below 130/80 (p=0.032) and LDL below 100 md/dl (p=0.018) than patients not on a statin. No significant difference in age, gender or A1c level was present between statin and non-statin use patients. Out of 978 total patients that had a recorded A1c level in their medical chart, 794 (81%) patients had a recent A1c level at 8% or less. Statin usage was comparable between ≤ 8% and > 8% A1c groups of patients, with Atorvastatin and Simvastatin being the most common statins used. CONCLUSIONS:  In this real-world observational study, only 50% of diabetes patients were on a statin. Diabetes patients taking a statin were more likely to have their blood pressure and LDL levels within national controls, compared to diabetes patients not on a statin.